<?xml version="1.0" encoding="UTF-8"  standalone="no" ?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1991-08-01" modified="2024-10-02" version="247" xmlns="http://uniprot.org/uniprot">
  <accession>P22314</accession>
  <accession>Q5JRR8</accession>
  <accession>Q96E13</accession>
  <name>UBA1_HUMAN</name>
  <protein>
    <recommendedName>
      <fullName>Ubiquitin-like modifier-activating enzyme 1</fullName>
      <ecNumber evidence="19">6.2.1.45</ecNumber>
    </recommendedName>
    <alternativeName>
      <fullName>Protein A1S9</fullName>
    </alternativeName>
    <alternativeName>
      <fullName>Ubiquitin-activating enzyme E1</fullName>
    </alternativeName>
  </protein>
  <gene>
    <name type="primary">UBA1</name>
    <name type="synonym">A1S9T</name>
    <name type="synonym">UBE1</name>
  </gene>
  <organism>
    <name type="scientific">Homo sapiens</name>
    <name type="common">Human</name>
    <dbReference type="NCBI Taxonomy" id="9606"/>
    <lineage>
      <taxon>Eukaryota</taxon>
      <taxon>Metazoa</taxon>
      <taxon>Chordata</taxon>
      <taxon>Craniata</taxon>
      <taxon>Vertebrata</taxon>
      <taxon>Euteleostomi</taxon>
      <taxon>Mammalia</taxon>
      <taxon>Eutheria</taxon>
      <taxon>Euarchontoglires</taxon>
      <taxon>Primates</taxon>
      <taxon>Haplorrhini</taxon>
      <taxon>Catarrhini</taxon>
      <taxon>Hominidae</taxon>
      <taxon>Homo</taxon>
    </lineage>
  </organism>
  <reference key="1">
    <citation type="journal article" date="1992" name="Cell Struct. Funct." volume="17" first="113" last="122">
      <title>Complementation by a cloned human ubiquitin-activating enzyme E1 of the S-phase-arrested mouse FM3A cell mutant with thermolabile E1.</title>
      <authorList>
        <person name="Ayusawa D."/>
        <person name="Kaneda S."/>
        <person name="Itoh Y."/>
        <person name="Yasuda H."/>
        <person name="Murakami Y."/>
        <person name="Sugasawa K."/>
        <person name="Hanaoka F."/>
        <person name="Seno T."/>
      </authorList>
      <dbReference type="PubMed" id="1606621"/>
      <dbReference type="DOI" id="10.1247/csf.17.113"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
    <scope>FUNCTION</scope>
    <scope>PATHWAY</scope>
  </reference>
  <reference key="2">
    <citation type="journal article" date="1991" name="Proc. Natl. Acad. Sci. U.S.A." volume="88" first="258" last="262">
      <title>Molecular cloning, sequence, and tissue distribution of the human ubiquitin-activating enzyme E1.</title>
      <authorList>
        <person name="Handley P.M."/>
        <person name="Mueckler M."/>
        <person name="Siegel N.R."/>
        <person name="Ciechanover A."/>
        <person name="Schwartz A.L."/>
      </authorList>
      <dbReference type="PubMed" id="1986373"/>
      <dbReference type="DOI" id="10.1073/pnas.88.1.258"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
    <scope>PROTEIN SEQUENCE OF 136-158; 369-383; 417-430 AND 559-580</scope>
    <scope>TISSUE SPECIFICITY</scope>
    <source>
      <tissue>Placenta</tissue>
    </source>
  </reference>
  <reference key="3">
    <citation type="journal article" date="1991" name="Proc. Natl. Acad. Sci. U.S.A." volume="88" first="7456" last="7456">
      <authorList>
        <person name="Handley P.M."/>
        <person name="Mueckler M."/>
        <person name="Siegel N.R."/>
        <person name="Ciechanover A."/>
        <person name="Schwartz A.L."/>
      </authorList>
      <dbReference type="PubMed" id="1871145"/>
      <dbReference type="DOI" id="10.1073/pnas.88.16.7456c"/>
    </citation>
    <scope>ERRATUM OF PUBMED:1986373</scope>
  </reference>
  <reference key="4">
    <citation type="journal article" date="2005" name="Nature" volume="434" first="325" last="337">
      <title>The DNA sequence of the human X chromosome.</title>
      <authorList>
        <person name="Ross M.T."/>
        <person name="Grafham D.V."/>
        <person name="Coffey A.J."/>
        <person name="Scherer S."/>
        <person name="McLay K."/>
        <person name="Muzny D."/>
        <person name="Platzer M."/>
        <person name="Howell G.R."/>
        <person name="Burrows C."/>
        <person name="Bird C.P."/>
        <person name="Frankish A."/>
        <person name="Lovell F.L."/>
        <person name="Howe K.L."/>
        <person name="Ashurst J.L."/>
        <person name="Fulton R.S."/>
        <person name="Sudbrak R."/>
        <person name="Wen G."/>
        <person name="Jones M.C."/>
        <person name="Hurles M.E."/>
        <person name="Andrews T.D."/>
        <person name="Scott C.E."/>
        <person name="Searle S."/>
        <person name="Ramser J."/>
        <person name="Whittaker A."/>
        <person name="Deadman R."/>
        <person name="Carter N.P."/>
        <person name="Hunt S.E."/>
        <person name="Chen R."/>
        <person name="Cree A."/>
        <person name="Gunaratne P."/>
        <person name="Havlak P."/>
        <person name="Hodgson A."/>
        <person name="Metzker M.L."/>
        <person name="Richards S."/>
        <person name="Scott G."/>
        <person name="Steffen D."/>
        <person name="Sodergren E."/>
        <person name="Wheeler D.A."/>
        <person name="Worley K.C."/>
        <person name="Ainscough R."/>
        <person name="Ambrose K.D."/>
        <person name="Ansari-Lari M.A."/>
        <person name="Aradhya S."/>
        <person name="Ashwell R.I."/>
        <person name="Babbage A.K."/>
        <person name="Bagguley C.L."/>
        <person name="Ballabio A."/>
        <person name="Banerjee R."/>
        <person name="Barker G.E."/>
        <person name="Barlow K.F."/>
        <person name="Barrett I.P."/>
        <person name="Bates K.N."/>
        <person name="Beare D.M."/>
        <person name="Beasley H."/>
        <person name="Beasley O."/>
        <person name="Beck A."/>
        <person name="Bethel G."/>
        <person name="Blechschmidt K."/>
        <person name="Brady N."/>
        <person name="Bray-Allen S."/>
        <person name="Bridgeman A.M."/>
        <person name="Brown A.J."/>
        <person name="Brown M.J."/>
        <person name="Bonnin D."/>
        <person name="Bruford E.A."/>
        <person name="Buhay C."/>
        <person name="Burch P."/>
        <person name="Burford D."/>
        <person name="Burgess J."/>
        <person name="Burrill W."/>
        <person name="Burton J."/>
        <person name="Bye J.M."/>
        <person name="Carder C."/>
        <person name="Carrel L."/>
        <person name="Chako J."/>
        <person name="Chapman J.C."/>
        <person name="Chavez D."/>
        <person name="Chen E."/>
        <person name="Chen G."/>
        <person name="Chen Y."/>
        <person name="Chen Z."/>
        <person name="Chinault C."/>
        <person name="Ciccodicola A."/>
        <person name="Clark S.Y."/>
        <person name="Clarke G."/>
        <person name="Clee C.M."/>
        <person name="Clegg S."/>
        <person name="Clerc-Blankenburg K."/>
        <person name="Clifford K."/>
        <person name="Cobley V."/>
        <person name="Cole C.G."/>
        <person name="Conquer J.S."/>
        <person name="Corby N."/>
        <person name="Connor R.E."/>
        <person name="David R."/>
        <person name="Davies J."/>
        <person name="Davis C."/>
        <person name="Davis J."/>
        <person name="Delgado O."/>
        <person name="Deshazo D."/>
        <person name="Dhami P."/>
        <person name="Ding Y."/>
        <person name="Dinh H."/>
        <person name="Dodsworth S."/>
        <person name="Draper H."/>
        <person name="Dugan-Rocha S."/>
        <person name="Dunham A."/>
        <person name="Dunn M."/>
        <person name="Durbin K.J."/>
        <person name="Dutta I."/>
        <person name="Eades T."/>
        <person name="Ellwood M."/>
        <person name="Emery-Cohen A."/>
        <person name="Errington H."/>
        <person name="Evans K.L."/>
        <person name="Faulkner L."/>
        <person name="Francis F."/>
        <person name="Frankland J."/>
        <person name="Fraser A.E."/>
        <person name="Galgoczy P."/>
        <person name="Gilbert J."/>
        <person name="Gill R."/>
        <person name="Gloeckner G."/>
        <person name="Gregory S.G."/>
        <person name="Gribble S."/>
        <person name="Griffiths C."/>
        <person name="Grocock R."/>
        <person name="Gu Y."/>
        <person name="Gwilliam R."/>
        <person name="Hamilton C."/>
        <person name="Hart E.A."/>
        <person name="Hawes A."/>
        <person name="Heath P.D."/>
        <person name="Heitmann K."/>
        <person name="Hennig S."/>
        <person name="Hernandez J."/>
        <person name="Hinzmann B."/>
        <person name="Ho S."/>
        <person name="Hoffs M."/>
        <person name="Howden P.J."/>
        <person name="Huckle E.J."/>
        <person name="Hume J."/>
        <person name="Hunt P.J."/>
        <person name="Hunt A.R."/>
        <person name="Isherwood J."/>
        <person name="Jacob L."/>
        <person name="Johnson D."/>
        <person name="Jones S."/>
        <person name="de Jong P.J."/>
        <person name="Joseph S.S."/>
        <person name="Keenan S."/>
        <person name="Kelly S."/>
        <person name="Kershaw J.K."/>
        <person name="Khan Z."/>
        <person name="Kioschis P."/>
        <person name="Klages S."/>
        <person name="Knights A.J."/>
        <person name="Kosiura A."/>
        <person name="Kovar-Smith C."/>
        <person name="Laird G.K."/>
        <person name="Langford C."/>
        <person name="Lawlor S."/>
        <person name="Leversha M."/>
        <person name="Lewis L."/>
        <person name="Liu W."/>
        <person name="Lloyd C."/>
        <person name="Lloyd D.M."/>
        <person name="Loulseged H."/>
        <person name="Loveland J.E."/>
        <person name="Lovell J.D."/>
        <person name="Lozado R."/>
        <person name="Lu J."/>
        <person name="Lyne R."/>
        <person name="Ma J."/>
        <person name="Maheshwari M."/>
        <person name="Matthews L.H."/>
        <person name="McDowall J."/>
        <person name="McLaren S."/>
        <person name="McMurray A."/>
        <person name="Meidl P."/>
        <person name="Meitinger T."/>
        <person name="Milne S."/>
        <person name="Miner G."/>
        <person name="Mistry S.L."/>
        <person name="Morgan M."/>
        <person name="Morris S."/>
        <person name="Mueller I."/>
        <person name="Mullikin J.C."/>
        <person name="Nguyen N."/>
        <person name="Nordsiek G."/>
        <person name="Nyakatura G."/>
        <person name="O'dell C.N."/>
        <person name="Okwuonu G."/>
        <person name="Palmer S."/>
        <person name="Pandian R."/>
        <person name="Parker D."/>
        <person name="Parrish J."/>
        <person name="Pasternak S."/>
        <person name="Patel D."/>
        <person name="Pearce A.V."/>
        <person name="Pearson D.M."/>
        <person name="Pelan S.E."/>
        <person name="Perez L."/>
        <person name="Porter K.M."/>
        <person name="Ramsey Y."/>
        <person name="Reichwald K."/>
        <person name="Rhodes S."/>
        <person name="Ridler K.A."/>
        <person name="Schlessinger D."/>
        <person name="Schueler M.G."/>
        <person name="Sehra H.K."/>
        <person name="Shaw-Smith C."/>
        <person name="Shen H."/>
        <person name="Sheridan E.M."/>
        <person name="Shownkeen R."/>
        <person name="Skuce C.D."/>
        <person name="Smith M.L."/>
        <person name="Sotheran E.C."/>
        <person name="Steingruber H.E."/>
        <person name="Steward C.A."/>
        <person name="Storey R."/>
        <person name="Swann R.M."/>
        <person name="Swarbreck D."/>
        <person name="Tabor P.E."/>
        <person name="Taudien S."/>
        <person name="Taylor T."/>
        <person name="Teague B."/>
        <person name="Thomas K."/>
        <person name="Thorpe A."/>
        <person name="Timms K."/>
        <person name="Tracey A."/>
        <person name="Trevanion S."/>
        <person name="Tromans A.C."/>
        <person name="d'Urso M."/>
        <person name="Verduzco D."/>
        <person name="Villasana D."/>
        <person name="Waldron L."/>
        <person name="Wall M."/>
        <person name="Wang Q."/>
        <person name="Warren J."/>
        <person name="Warry G.L."/>
        <person name="Wei X."/>
        <person name="West A."/>
        <person name="Whitehead S.L."/>
        <person name="Whiteley M.N."/>
        <person name="Wilkinson J.E."/>
        <person name="Willey D.L."/>
        <person name="Williams G."/>
        <person name="Williams L."/>
        <person name="Williamson A."/>
        <person name="Williamson H."/>
        <person name="Wilming L."/>
        <person name="Woodmansey R.L."/>
        <person name="Wray P.W."/>
        <person name="Yen J."/>
        <person name="Zhang J."/>
        <person name="Zhou J."/>
        <person name="Zoghbi H."/>
        <person name="Zorilla S."/>
        <person name="Buck D."/>
        <person name="Reinhardt R."/>
        <person name="Poustka A."/>
        <person name="Rosenthal A."/>
        <person name="Lehrach H."/>
        <person name="Meindl A."/>
        <person name="Minx P.J."/>
        <person name="Hillier L.W."/>
        <person name="Willard H.F."/>
        <person name="Wilson R.K."/>
        <person name="Waterston R.H."/>
        <person name="Rice C.M."/>
        <person name="Vaudin M."/>
        <person name="Coulson A."/>
        <person name="Nelson D.L."/>
        <person name="Weinstock G."/>
        <person name="Sulston J.E."/>
        <person name="Durbin R.M."/>
        <person name="Hubbard T."/>
        <person name="Gibbs R.A."/>
        <person name="Beck S."/>
        <person name="Rogers J."/>
        <person name="Bentley D.R."/>
      </authorList>
      <dbReference type="PubMed" id="15772651"/>
      <dbReference type="DOI" id="10.1038/nature03440"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
  </reference>
  <reference key="5">
    <citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
      <authorList>
        <person name="Mural R.J."/>
        <person name="Istrail S."/>
        <person name="Sutton G.G."/>
        <person name="Florea L."/>
        <person name="Halpern A.L."/>
        <person name="Mobarry C.M."/>
        <person name="Lippert R."/>
        <person name="Walenz B."/>
        <person name="Shatkay H."/>
        <person name="Dew I."/>
        <person name="Miller J.R."/>
        <person name="Flanigan M.J."/>
        <person name="Edwards N.J."/>
        <person name="Bolanos R."/>
        <person name="Fasulo D."/>
        <person name="Halldorsson B.V."/>
        <person name="Hannenhalli S."/>
        <person name="Turner R."/>
        <person name="Yooseph S."/>
        <person name="Lu F."/>
        <person name="Nusskern D.R."/>
        <person name="Shue B.C."/>
        <person name="Zheng X.H."/>
        <person name="Zhong F."/>
        <person name="Delcher A.L."/>
        <person name="Huson D.H."/>
        <person name="Kravitz S.A."/>
        <person name="Mouchard L."/>
        <person name="Reinert K."/>
        <person name="Remington K.A."/>
        <person name="Clark A.G."/>
        <person name="Waterman M.S."/>
        <person name="Eichler E.E."/>
        <person name="Adams M.D."/>
        <person name="Hunkapiller M.W."/>
        <person name="Myers E.W."/>
        <person name="Venter J.C."/>
      </authorList>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
  </reference>
  <reference key="6">
    <citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
      <title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
      <authorList>
        <consortium name="The MGC Project Team"/>
      </authorList>
      <dbReference type="PubMed" id="15489334"/>
      <dbReference type="DOI" id="10.1101/gr.2596504"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
    <source>
      <tissue>Lymph</tissue>
    </source>
  </reference>
  <reference key="7">
    <citation type="journal article" date="1990" name="EMBO J." volume="9" first="2923" last="2929">
      <title>Molecular cloning, primary structure and expression of the human X linked A1S9 gene cDNA which complements the ts A1S9 mouse L cell defect in DNA replication.</title>
      <authorList>
        <person name="Zacksenhaus E."/>
        <person name="Sheinin R."/>
      </authorList>
      <dbReference type="PubMed" id="2390975"/>
      <dbReference type="DOI" id="10.1002/j.1460-2075.1990.tb07483.x"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [MRNA] OF 257-989</scope>
  </reference>
  <reference key="8">
    <citation type="submission" date="2007-03" db="UniProtKB">
      <authorList>
        <person name="Lubec G."/>
        <person name="Vishwanath V."/>
      </authorList>
    </citation>
    <scope>PROTEIN SEQUENCE OF 559-581 AND 924-944</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
    <source>
      <tissue>Brain</tissue>
      <tissue>Cajal-Retzius cell</tissue>
    </source>
  </reference>
  <reference key="9">
    <citation type="journal article" date="1992" name="J. Biol. Chem." volume="267" first="24315" last="24321">
      <title>Isoforms of mammalian ubiquitin-activating enzyme.</title>
      <authorList>
        <person name="Cook J.C."/>
        <person name="Chock P.B."/>
      </authorList>
      <dbReference type="PubMed" id="1447181"/>
      <dbReference type="DOI" id="10.1016/s0021-9258(18)35767-3"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>CATALYTIC ACTIVITY</scope>
    <scope>ALTERNATIVE SPLICING</scope>
    <scope>PATHWAY</scope>
  </reference>
  <reference key="10">
    <citation type="journal article" date="1992" name="Proc. Natl. Acad. Sci. U.S.A." volume="89" first="5542" last="5546">
      <title>Immunoelectron microscopic localization of the ubiquitin-activating enzyme E1 in HepG2 cells.</title>
      <authorList>
        <person name="Schwartz A.L."/>
        <person name="Trausch J.S."/>
        <person name="Ciechanover A."/>
        <person name="Slot J.W."/>
        <person name="Geuze H."/>
      </authorList>
      <dbReference type="PubMed" id="1376922"/>
      <dbReference type="DOI" id="10.1073/pnas.89.12.5542"/>
    </citation>
    <scope>SUBCELLULAR LOCATION</scope>
  </reference>
  <reference key="11">
    <citation type="journal article" date="1994" name="J. Biol. Chem." volume="269" first="33171" last="33178">
      <title>Human ubiquitin-activating enzyme, E1. Indication of potential nuclear and cytoplasmic subpopulations using epitope-tagged cDNA constructs.</title>
      <authorList>
        <person name="Handley-Gearhart P.M."/>
        <person name="Stephen A.G."/>
        <person name="Trausch-Azar J.S."/>
        <person name="Ciechanover A."/>
        <person name="Schwartz A.L."/>
      </authorList>
      <dbReference type="PubMed" id="7528747"/>
      <dbReference type="DOI" id="10.1016/s0021-9258(20)30113-7"/>
    </citation>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>CHARACTERIZATION OF ISOFORM 1 AND ISOFORM 2</scope>
  </reference>
  <reference key="12">
    <citation type="journal article" date="1997" name="J. Biol. Chem." volume="272" first="10895" last="10903">
      <title>Identification of a region within the ubiquitin-activating enzyme required for nuclear targeting and phosphorylation.</title>
      <authorList>
        <person name="Stephen A.G."/>
        <person name="Trausch-Azar J.S."/>
        <person name="Handley-Gearhart P.M."/>
        <person name="Ciechanover A."/>
        <person name="Schwartz A.L."/>
      </authorList>
      <dbReference type="PubMed" id="9099746"/>
      <dbReference type="DOI" id="10.1074/jbc.272.16.10895"/>
    </citation>
    <scope>PHOSPHORYLATION AT SER-4</scope>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>MUTAGENESIS OF SER-4 AND 8-LYS--ARG-11</scope>
  </reference>
  <reference key="13">
    <citation type="journal article" date="2005" name="Biochem. Biophys. Res. Commun." volume="336" first="496" last="506">
      <title>Proteomic identification of proteins conjugated to ISG15 in mouse and human cells.</title>
      <authorList>
        <person name="Giannakopoulos N.V."/>
        <person name="Luo J.K."/>
        <person name="Papov V."/>
        <person name="Zou W."/>
        <person name="Lenschow D.J."/>
        <person name="Jacobs B.S."/>
        <person name="Borden E.C."/>
        <person name="Li J."/>
        <person name="Virgin H.W."/>
        <person name="Zhang D.E."/>
      </authorList>
      <dbReference type="PubMed" id="16139798"/>
      <dbReference type="DOI" id="10.1016/j.bbrc.2005.08.132"/>
    </citation>
    <scope>ISGYLATION</scope>
  </reference>
  <reference key="14">
    <citation type="journal article" date="2005" name="Nat. Biotechnol." volume="23" first="94" last="101">
      <title>Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.</title>
      <authorList>
        <person name="Rush J."/>
        <person name="Moritz A."/>
        <person name="Lee K.A."/>
        <person name="Guo A."/>
        <person name="Goss V.L."/>
        <person name="Spek E.J."/>
        <person name="Zhang H."/>
        <person name="Zha X.-M."/>
        <person name="Polakiewicz R.D."/>
        <person name="Comb M.J."/>
      </authorList>
      <dbReference type="PubMed" id="15592455"/>
      <dbReference type="DOI" id="10.1038/nbt1046"/>
    </citation>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="15">
    <citation type="journal article" date="2005" name="Nature" volume="438" first="224" last="228">
      <title>Gigaxonin-controlled degradation of MAP1B light chain is critical to neuronal survival.</title>
      <authorList>
        <person name="Allen E."/>
        <person name="Ding J."/>
        <person name="Wang W."/>
        <person name="Pramanik S."/>
        <person name="Chou J."/>
        <person name="Yau V."/>
        <person name="Yang Y."/>
      </authorList>
      <dbReference type="PubMed" id="16227972"/>
      <dbReference type="DOI" id="10.1038/nature04256"/>
    </citation>
    <scope>INTERACTION WITH GAN</scope>
  </reference>
  <reference key="16">
    <citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
      <title>A quantitative atlas of mitotic phosphorylation.</title>
      <authorList>
        <person name="Dephoure N."/>
        <person name="Zhou C."/>
        <person name="Villen J."/>
        <person name="Beausoleil S.A."/>
        <person name="Bakalarski C.E."/>
        <person name="Elledge S.J."/>
        <person name="Gygi S.P."/>
      </authorList>
      <dbReference type="PubMed" id="18669648"/>
      <dbReference type="DOI" id="10.1073/pnas.0805139105"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-13; SER-46; THR-800 AND SER-835</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Cervix carcinoma</tissue>
    </source>
  </reference>
  <reference key="17">
    <citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
      <title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
      <authorList>
        <person name="Gauci S."/>
        <person name="Helbig A.O."/>
        <person name="Slijper M."/>
        <person name="Krijgsveld J."/>
        <person name="Heck A.J."/>
        <person name="Mohammed S."/>
      </authorList>
      <dbReference type="PubMed" id="19413330"/>
      <dbReference type="DOI" id="10.1021/ac9004309"/>
    </citation>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="18">
    <citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
      <title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
      <authorList>
        <person name="Mayya V."/>
        <person name="Lundgren D.H."/>
        <person name="Hwang S.-I."/>
        <person name="Rezaul K."/>
        <person name="Wu L."/>
        <person name="Eng J.K."/>
        <person name="Rodionov V."/>
        <person name="Han D.K."/>
      </authorList>
      <dbReference type="PubMed" id="19690332"/>
      <dbReference type="DOI" id="10.1126/scisignal.2000007"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-46 AND SER-810</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Leukemic T-cell</tissue>
    </source>
  </reference>
  <reference key="19">
    <citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
      <title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
      <authorList>
        <person name="Choudhary C."/>
        <person name="Kumar C."/>
        <person name="Gnad F."/>
        <person name="Nielsen M.L."/>
        <person name="Rehman M."/>
        <person name="Walther T.C."/>
        <person name="Olsen J.V."/>
        <person name="Mann M."/>
      </authorList>
      <dbReference type="PubMed" id="19608861"/>
      <dbReference type="DOI" id="10.1126/science.1175371"/>
    </citation>
    <scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-671 AND LYS-980</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="20">
    <citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
      <title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
      <authorList>
        <person name="Olsen J.V."/>
        <person name="Vermeulen M."/>
        <person name="Santamaria A."/>
        <person name="Kumar C."/>
        <person name="Miller M.L."/>
        <person name="Jensen L.J."/>
        <person name="Gnad F."/>
        <person name="Cox J."/>
        <person name="Jensen T.S."/>
        <person name="Nigg E.A."/>
        <person name="Brunak S."/>
        <person name="Mann M."/>
      </authorList>
      <dbReference type="PubMed" id="20068231"/>
      <dbReference type="DOI" id="10.1126/scisignal.2000475"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-46 AND SER-810</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Cervix carcinoma</tissue>
    </source>
  </reference>
  <reference key="21">
    <citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
      <title>Initial characterization of the human central proteome.</title>
      <authorList>
        <person name="Burkard T.R."/>
        <person name="Planyavsky M."/>
        <person name="Kaupe I."/>
        <person name="Breitwieser F.P."/>
        <person name="Buerckstuemmer T."/>
        <person name="Bennett K.L."/>
        <person name="Superti-Furga G."/>
        <person name="Colinge J."/>
      </authorList>
      <dbReference type="PubMed" id="21269460"/>
      <dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
    </citation>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="22">
    <citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
      <title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
      <authorList>
        <person name="Rigbolt K.T."/>
        <person name="Prokhorova T.A."/>
        <person name="Akimov V."/>
        <person name="Henningsen J."/>
        <person name="Johansen P.T."/>
        <person name="Kratchmarova I."/>
        <person name="Kassem M."/>
        <person name="Mann M."/>
        <person name="Olsen J.V."/>
        <person name="Blagoev B."/>
      </authorList>
      <dbReference type="PubMed" id="21406692"/>
      <dbReference type="DOI" id="10.1126/scisignal.2001570"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-46</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="23">
    <citation type="journal article" date="2012" name="Cell Cycle" volume="11" first="1573" last="1582">
      <title>Ubiquitin-activating enzyme UBA1 is required for cellular response to DNA damage.</title>
      <authorList>
        <person name="Moudry P."/>
        <person name="Lukas C."/>
        <person name="Macurek L."/>
        <person name="Hanzlikova H."/>
        <person name="Hodny Z."/>
        <person name="Lukas J."/>
        <person name="Bartek J."/>
      </authorList>
      <dbReference type="PubMed" id="22456334"/>
      <dbReference type="DOI" id="10.4161/cc.19978"/>
    </citation>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>FUNCTION</scope>
  </reference>
  <reference key="24">
    <citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12449" last="12454">
      <title>N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.</title>
      <authorList>
        <person name="Van Damme P."/>
        <person name="Lasa M."/>
        <person name="Polevoda B."/>
        <person name="Gazquez C."/>
        <person name="Elosegui-Artola A."/>
        <person name="Kim D.S."/>
        <person name="De Juan-Pardo E."/>
        <person name="Demeyer K."/>
        <person name="Hole K."/>
        <person name="Larrea E."/>
        <person name="Timmerman E."/>
        <person name="Prieto J."/>
        <person name="Arnesen T."/>
        <person name="Sherman F."/>
        <person name="Gevaert K."/>
        <person name="Aldabe R."/>
      </authorList>
      <dbReference type="PubMed" id="22814378"/>
      <dbReference type="DOI" id="10.1073/pnas.1210303109"/>
    </citation>
    <scope>ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2</scope>
    <scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2 (ISOFORM 2)</scope>
    <scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
    <scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS] (ISOFORM 2)</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="25">
    <citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
      <title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
      <authorList>
        <person name="Zhou H."/>
        <person name="Di Palma S."/>
        <person name="Preisinger C."/>
        <person name="Peng M."/>
        <person name="Polat A.N."/>
        <person name="Heck A.J."/>
        <person name="Mohammed S."/>
      </authorList>
      <dbReference type="PubMed" id="23186163"/>
      <dbReference type="DOI" id="10.1021/pr300630k"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-46 AND SER-835</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Cervix carcinoma</tissue>
      <tissue>Erythroleukemia</tissue>
    </source>
  </reference>
  <reference key="26">
    <citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
      <title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
      <authorList>
        <person name="Bian Y."/>
        <person name="Song C."/>
        <person name="Cheng K."/>
        <person name="Dong M."/>
        <person name="Wang F."/>
        <person name="Huang J."/>
        <person name="Sun D."/>
        <person name="Wang L."/>
        <person name="Ye M."/>
        <person name="Zou H."/>
      </authorList>
      <dbReference type="PubMed" id="24275569"/>
      <dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-820</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Liver</tissue>
    </source>
  </reference>
  <reference key="27">
    <citation type="journal article" date="2015" name="Proteomics" volume="15" first="2519" last="2524">
      <title>N-terminome analysis of the human mitochondrial proteome.</title>
      <authorList>
        <person name="Vaca Jacome A.S."/>
        <person name="Rabilloud T."/>
        <person name="Schaeffer-Reiss C."/>
        <person name="Rompais M."/>
        <person name="Ayoub D."/>
        <person name="Lane L."/>
        <person name="Bairoch A."/>
        <person name="Van Dorsselaer A."/>
        <person name="Carapito C."/>
      </authorList>
      <dbReference type="PubMed" id="25944712"/>
      <dbReference type="DOI" id="10.1002/pmic.201400617"/>
    </citation>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="28">
    <citation type="journal article" date="2020" name="N. Engl. J. Med." volume="383" first="2628" last="2638">
      <title>Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease.</title>
      <authorList>
        <person name="Beck D.B."/>
        <person name="Ferrada M.A."/>
        <person name="Sikora K.A."/>
        <person name="Ombrello A.K."/>
        <person name="Collins J.C."/>
        <person name="Pei W."/>
        <person name="Balanda N."/>
        <person name="Ross D.L."/>
        <person name="Ospina Cardona D."/>
        <person name="Wu Z."/>
        <person name="Patel B."/>
        <person name="Manthiram K."/>
        <person name="Groarke E.M."/>
        <person name="Gutierrez-Rodrigues F."/>
        <person name="Hoffmann P."/>
        <person name="Rosenzweig S."/>
        <person name="Nakabo S."/>
        <person name="Dillon L.W."/>
        <person name="Hourigan C.S."/>
        <person name="Tsai W.L."/>
        <person name="Gupta S."/>
        <person name="Carmona-Rivera C."/>
        <person name="Asmar A.J."/>
        <person name="Xu L."/>
        <person name="Oda H."/>
        <person name="Goodspeed W."/>
        <person name="Barron K.S."/>
        <person name="Nehrebecky M."/>
        <person name="Jones A."/>
        <person name="Laird R.S."/>
        <person name="Deuitch N."/>
        <person name="Rowczenio D."/>
        <person name="Rominger E."/>
        <person name="Wells K.V."/>
        <person name="Lee C.R."/>
        <person name="Wang W."/>
        <person name="Trick M."/>
        <person name="Mullikin J."/>
        <person name="Wigerblad G."/>
        <person name="Brooks S."/>
        <person name="Dell'Orso S."/>
        <person name="Deng Z."/>
        <person name="Chae J.J."/>
        <person name="Dulau-Florea A."/>
        <person name="Malicdan M.C.V."/>
        <person name="Novacic D."/>
        <person name="Colbert R.A."/>
        <person name="Kaplan M.J."/>
        <person name="Gadina M."/>
        <person name="Savic S."/>
        <person name="Lachmann H.J."/>
        <person name="Abu-Asab M."/>
        <person name="Solomon B.D."/>
        <person name="Retterer K."/>
        <person name="Gahl W.A."/>
        <person name="Burgess S.M."/>
        <person name="Aksentijevich I."/>
        <person name="Young N.S."/>
        <person name="Calvo K.R."/>
        <person name="Werner A."/>
        <person name="Kastner D.L."/>
        <person name="Grayson P.C."/>
      </authorList>
      <dbReference type="PubMed" id="33108101"/>
      <dbReference type="DOI" id="10.1056/nejmoa2026834"/>
    </citation>
    <scope>INVOLVEMENT IN VEXAS</scope>
    <scope>VARIANTS VEXAS LEU-41; THR-41 AND VAL-41</scope>
    <scope>CHARACTERIZATION OF VARIANT VEXAS VAL-41</scope>
    <scope>FUNCTION</scope>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>MUTAGENESIS OF 1-MET--ALA-66; 1-MET--GLY-40; MET-41 AND MET-67</scope>
  </reference>
  <reference key="29">
    <citation type="journal article" date="2014" name="Biosci. Biotechnol. Biochem." volume="78" first="1542" last="1549">
      <title>Expression, purification, and crystal structure of N-terminal domains of human ubiquitin-activating enzyme (E1).</title>
      <authorList>
        <person name="Xie S.T."/>
      </authorList>
      <dbReference type="PubMed" id="25209502"/>
      <dbReference type="DOI" id="10.1080/09168451.2014.923301"/>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (2.75 ANGSTROMS) OF 1-439</scope>
  </reference>
  <reference key="30">
    <citation type="journal article" date="2008" name="Am. J. Hum. Genet." volume="82" first="188" last="193">
      <title>Rare missense and synonymous variants in UBE1 are associated with X-linked infantile spinal muscular atrophy.</title>
      <authorList>
        <person name="Ramser J."/>
        <person name="Ahearn M.E."/>
        <person name="Lenski C."/>
        <person name="Yariz K.O."/>
        <person name="Hellebrand H."/>
        <person name="von Rhein M."/>
        <person name="Clark R.D."/>
        <person name="Schmutzler R.K."/>
        <person name="Lichtner P."/>
        <person name="Hoffman E.P."/>
        <person name="Meindl A."/>
        <person name="Baumbach-Reardon L."/>
      </authorList>
      <dbReference type="PubMed" id="18179898"/>
      <dbReference type="DOI" id="10.1016/j.ajhg.2007.09.009"/>
    </citation>
    <scope>VARIANTS SMAX2 ILE-539 AND GLY-547</scope>
  </reference>
  <reference key="31">
    <citation type="journal article" date="2013" name="Neuromuscul. Disord." volume="23" first="391" last="398">
      <title>Clinical and neuropathological features of X-linked spinal muscular atrophy (SMAX2) associated with a novel mutation in the UBA1 gene.</title>
      <authorList>
        <person name="Dlamini N."/>
        <person name="Josifova D.J."/>
        <person name="Paine S.M."/>
        <person name="Wraige E."/>
        <person name="Pitt M."/>
        <person name="Murphy A.J."/>
        <person name="King A."/>
        <person name="Buk S."/>
        <person name="Smith F."/>
        <person name="Abbs S."/>
        <person name="Sewry C."/>
        <person name="Jacques T.S."/>
        <person name="Jungbluth H."/>
      </authorList>
      <dbReference type="PubMed" id="23518311"/>
      <dbReference type="DOI" id="10.1016/j.nmd.2013.02.001"/>
    </citation>
    <scope>VARIANT SMAX2 VAL-557</scope>
  </reference>
  <comment type="function">
    <text evidence="7 8 13 15">Catalyzes the first step in ubiquitin conjugation to mark cellular proteins for degradation through the ubiquitin-proteasome system (PubMed:1447181, PubMed:1606621, PubMed:33108101). Activates ubiquitin by first adenylating its C-terminal glycine residue with ATP, and thereafter linking this residue to the side chain of a cysteine residue in E1, yielding a ubiquitin-E1 thioester and free AMP (PubMed:1447181). Essential for the formation of radiation-induced foci, timely DNA repair and for response to replication stress. Promotes the recruitment of TP53BP1 and BRCA1 at DNA damage sites (PubMed:22456334).</text>
  </comment>
  <comment type="catalytic activity">
    <reaction evidence="19">
      <text>ATP + ubiquitin + [E1 ubiquitin-activating enzyme]-L-cysteine = AMP + diphosphate + S-ubiquitinyl-[E1 ubiquitin-activating enzyme]-L-cysteine.</text>
      <dbReference type="EC" id="6.2.1.45"/>
    </reaction>
  </comment>
  <comment type="pathway">
    <text evidence="7 8">Protein modification; protein ubiquitination.</text>
  </comment>
  <comment type="subunit">
    <text evidence="1 10">Monomer (By similarity). Interacts with GAN (via BTB domain).</text>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-709688">
      <id>P22314</id>
    </interactant>
    <interactant intactId="EBI-764342">
      <id>Q9H2C0</id>
      <label>GAN</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>3</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-709688">
      <id>P22314</id>
    </interactant>
    <interactant intactId="EBI-466029">
      <id>P42858</id>
      <label>HTT</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>3</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-709688">
      <id>P22314</id>
    </interactant>
    <interactant intactId="EBI-1058491">
      <id>Q96FW1</id>
      <label>OTUB1</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>4</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-709688">
      <id>P22314</id>
    </interactant>
    <interactant intactId="EBI-3650647">
      <id>Q9BUZ4</id>
      <label>TRAF4</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>3</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-709688">
      <id>P22314</id>
    </interactant>
    <interactant intactId="EBI-80168">
      <id>P63279</id>
      <label>UBE2I</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>2</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-709688">
      <id>P22314</id>
    </interactant>
    <interactant intactId="EBI-743923">
      <id>O00308</id>
      <label>WWP2</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>3</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-709688">
      <id>P22314</id>
    </interactant>
    <interactant intactId="EBI-6248077">
      <id>Q76353</id>
    </interactant>
    <organismsDiffer>true</organismsDiffer>
    <experiments>2</experiments>
  </comment>
  <comment type="subcellular location">
    <subcellularLocation>
      <location evidence="6">Cytoplasm</location>
    </subcellularLocation>
    <subcellularLocation>
      <location evidence="6">Mitochondrion</location>
    </subcellularLocation>
    <subcellularLocation>
      <location evidence="6 13">Nucleus</location>
    </subcellularLocation>
  </comment>
  <comment type="subcellular location">
    <molecule>Isoform 1</molecule>
    <subcellularLocation>
      <location evidence="15 16 17">Nucleus</location>
    </subcellularLocation>
  </comment>
  <comment type="subcellular location">
    <molecule>Isoform 2</molecule>
    <subcellularLocation>
      <location evidence="15 16">Cytoplasm</location>
    </subcellularLocation>
  </comment>
  <comment type="alternative products">
    <event type="alternative initiation"/>
    <isoform>
      <id>P22314-1</id>
      <name>1</name>
      <name>E1a</name>
      <sequence type="displayed"/>
    </isoform>
    <isoform>
      <id>P22314-2</id>
      <name>2</name>
      <name>E1b</name>
      <sequence type="described" ref="VSP_055913"/>
    </isoform>
  </comment>
  <comment type="tissue specificity">
    <text evidence="12">Detected in erythrocytes (at protein level). Ubiquitous.</text>
  </comment>
  <comment type="domain">
    <text>The first 11 amino acids are essential for phosphorylation and exclusive nuclear localization.</text>
  </comment>
  <comment type="PTM">
    <text evidence="9">ISGylated.</text>
  </comment>
  <comment type="disease" evidence="11 14">
    <disease id="DI-01059">
      <name>Spinal muscular atrophy X-linked 2</name>
      <acronym>SMAX2</acronym>
      <description>A lethal infantile form of spinal muscular atrophy, a neuromuscular disorder characterized by degeneration of the anterior horn cells of the spinal cord, leading to symmetrical muscle weakness and atrophy. Clinical features include hypotonia, areflexia, and multiple congenital contractures.</description>
      <dbReference type="MIM" id="301830"/>
    </disease>
    <text>The disease is caused by variants affecting the gene represented in this entry.</text>
  </comment>
  <comment type="disease" evidence="15">
    <disease id="DI-05955">
      <name>VEXAS syndrome</name>
      <acronym>VEXAS</acronym>
      <description>A sporadic, often fatal, treatment-refractory inflammatory syndrome that develops in late adulthood. Clinical features include fevers, cytopenias, characteristic vacuoles in myeloid and erythroid precursor cells, dysplastic bone marrow, neutrophilic cutaneous and pulmonary inflammation, chondritis, and vasculitis. The disease affects only males and is associated with de novo somatic mutations.</description>
      <dbReference type="MIM" id="301054"/>
    </disease>
    <text evidence="15">The disease is caused by variants affecting the gene represented in this entry. Somatic variants affecting the initiator methionine of isoform 2 are recurrently found in VEXAS patients. These variants cause loss of isoform 2 and production of a shorter isoform with strongly reduced enzymatic activity from a downstream methionine (Met-67).</text>
  </comment>
  <comment type="miscellaneous">
    <text evidence="2">There are two active sites within the E1 molecule, allowing it to accommodate two ubiquitin moieties at a time, with a new ubiquitin forming an adenylate intermediate as the previous one is transferred to the thiol site.</text>
  </comment>
  <comment type="similarity">
    <text evidence="18">Belongs to the ubiquitin-activating E1 family.</text>
  </comment>
  <dbReference type="EC" id="6.2.1.45" evidence="19"/>
  <dbReference type="EMBL" id="X56976">
    <property type="protein sequence ID" value="CAA40296.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="M58028">
    <property type="protein sequence ID" value="AAA61246.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="AL513366">
    <property type="status" value="NOT_ANNOTATED_CDS"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="CH471164">
    <property type="protein sequence ID" value="EAW59290.1"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="BC013041">
    <property type="protein sequence ID" value="AAH13041.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="X52897">
    <property type="protein sequence ID" value="CAA37078.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="CCDS" id="CCDS14275.1">
    <molecule id="P22314-1"/>
  </dbReference>
  <dbReference type="PIR" id="A38564">
    <property type="entry name" value="A38564"/>
  </dbReference>
  <dbReference type="RefSeq" id="NP_003325.2">
    <molecule id="P22314-1"/>
    <property type="nucleotide sequence ID" value="NM_003334.3"/>
  </dbReference>
  <dbReference type="RefSeq" id="NP_695012.1">
    <molecule id="P22314-1"/>
    <property type="nucleotide sequence ID" value="NM_153280.2"/>
  </dbReference>
  <dbReference type="RefSeq" id="XP_016885269.1">
    <molecule id="P22314-1"/>
    <property type="nucleotide sequence ID" value="XM_017029780.1"/>
  </dbReference>
  <dbReference type="RefSeq" id="XP_016885270.1">
    <property type="nucleotide sequence ID" value="XM_017029781.1"/>
  </dbReference>
  <dbReference type="PDB" id="4P22">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.75 A"/>
    <property type="chains" value="A/B=1-439"/>
  </dbReference>
  <dbReference type="PDB" id="6DC6">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.14 A"/>
    <property type="chains" value="A/C=49-1058"/>
  </dbReference>
  <dbReference type="PDB" id="7PYV">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.27 A"/>
    <property type="chains" value="A/B=631-899"/>
  </dbReference>
  <dbReference type="PDBsum" id="4P22"/>
  <dbReference type="PDBsum" id="6DC6"/>
  <dbReference type="PDBsum" id="7PYV"/>
  <dbReference type="AlphaFoldDB" id="P22314"/>
  <dbReference type="SMR" id="P22314"/>
  <dbReference type="BioGRID" id="113165">
    <property type="interactions" value="365"/>
  </dbReference>
  <dbReference type="DIP" id="DIP-33686N"/>
  <dbReference type="IntAct" id="P22314">
    <property type="interactions" value="195"/>
  </dbReference>
  <dbReference type="MINT" id="P22314"/>
  <dbReference type="STRING" id="9606.ENSP00000338413"/>
  <dbReference type="BindingDB" id="P22314"/>
  <dbReference type="ChEMBL" id="CHEMBL5924"/>
  <dbReference type="DrugBank" id="DB04119">
    <property type="generic name" value="Hexatantalum Dodecabromide"/>
  </dbReference>
  <dbReference type="DrugBank" id="DB04216">
    <property type="generic name" value="Quercetin"/>
  </dbReference>
  <dbReference type="GlyCosmos" id="P22314">
    <property type="glycosylation" value="3 sites, 1 glycan"/>
  </dbReference>
  <dbReference type="GlyGen" id="P22314">
    <property type="glycosylation" value="7 sites, 1 O-linked glycan (7 sites)"/>
  </dbReference>
  <dbReference type="iPTMnet" id="P22314"/>
  <dbReference type="MetOSite" id="P22314"/>
  <dbReference type="PhosphoSitePlus" id="P22314"/>
  <dbReference type="SwissPalm" id="P22314"/>
  <dbReference type="BioMuta" id="UBA1"/>
  <dbReference type="DMDM" id="24418865"/>
  <dbReference type="REPRODUCTION-2DPAGE" id="IPI00645078"/>
  <dbReference type="CPTAC" id="CPTAC-136"/>
  <dbReference type="CPTAC" id="CPTAC-137"/>
  <dbReference type="jPOST" id="P22314"/>
  <dbReference type="MassIVE" id="P22314"/>
  <dbReference type="PaxDb" id="9606-ENSP00000338413"/>
  <dbReference type="PeptideAtlas" id="P22314"/>
  <dbReference type="PRIDE" id="P22314"/>
  <dbReference type="ProteomicsDB" id="53983">
    <molecule id="P22314-1"/>
  </dbReference>
  <dbReference type="Pumba" id="P22314"/>
  <dbReference type="Antibodypedia" id="345">
    <property type="antibodies" value="467 antibodies from 40 providers"/>
  </dbReference>
  <dbReference type="CPTC" id="P22314">
    <property type="antibodies" value="3 antibodies"/>
  </dbReference>
  <dbReference type="DNASU" id="7317"/>
  <dbReference type="Ensembl" id="ENST00000335972.11">
    <molecule id="P22314-1"/>
    <property type="protein sequence ID" value="ENSP00000338413.6"/>
    <property type="gene ID" value="ENSG00000130985.17"/>
  </dbReference>
  <dbReference type="Ensembl" id="ENST00000377351.8">
    <molecule id="P22314-1"/>
    <property type="protein sequence ID" value="ENSP00000366568.4"/>
    <property type="gene ID" value="ENSG00000130985.17"/>
  </dbReference>
  <dbReference type="GeneID" id="7317"/>
  <dbReference type="KEGG" id="hsa:7317"/>
  <dbReference type="MANE-Select" id="ENST00000335972.11">
    <property type="protein sequence ID" value="ENSP00000338413.6"/>
    <property type="RefSeq nucleotide sequence ID" value="NM_003334.4"/>
    <property type="RefSeq protein sequence ID" value="NP_003325.2"/>
  </dbReference>
  <dbReference type="UCSC" id="uc004dhj.5">
    <molecule id="P22314-1"/>
    <property type="organism name" value="human"/>
  </dbReference>
  <dbReference type="AGR" id="HGNC:12469"/>
  <dbReference type="CTD" id="7317"/>
  <dbReference type="DisGeNET" id="7317"/>
  <dbReference type="GeneCards" id="UBA1"/>
  <dbReference type="GeneReviews" id="UBA1"/>
  <dbReference type="HGNC" id="HGNC:12469">
    <property type="gene designation" value="UBA1"/>
  </dbReference>
  <dbReference type="HPA" id="ENSG00000130985">
    <property type="expression patterns" value="Low tissue specificity"/>
  </dbReference>
  <dbReference type="MalaCards" id="UBA1"/>
  <dbReference type="MIM" id="301054">
    <property type="type" value="phenotype"/>
  </dbReference>
  <dbReference type="MIM" id="301830">
    <property type="type" value="phenotype"/>
  </dbReference>
  <dbReference type="MIM" id="314370">
    <property type="type" value="gene"/>
  </dbReference>
  <dbReference type="neXtProt" id="NX_P22314"/>
  <dbReference type="OpenTargets" id="ENSG00000130985"/>
  <dbReference type="Orphanet" id="1145">
    <property type="disease" value="Infantile-onset X-linked spinal muscular atrophy"/>
  </dbReference>
  <dbReference type="Orphanet" id="596753">
    <property type="disease" value="VEXAS syndrome"/>
  </dbReference>
  <dbReference type="PharmGKB" id="PA37119"/>
  <dbReference type="VEuPathDB" id="HostDB:ENSG00000130985"/>
  <dbReference type="eggNOG" id="KOG2012">
    <property type="taxonomic scope" value="Eukaryota"/>
  </dbReference>
  <dbReference type="GeneTree" id="ENSGT00940000158975"/>
  <dbReference type="HOGENOM" id="CLU_002556_0_0_1"/>
  <dbReference type="InParanoid" id="P22314"/>
  <dbReference type="OMA" id="GANLHAF"/>
  <dbReference type="OrthoDB" id="20494at2759"/>
  <dbReference type="PhylomeDB" id="P22314"/>
  <dbReference type="TreeFam" id="TF300586"/>
  <dbReference type="BioCyc" id="MetaCyc:HS05465-MONOMER"/>
  <dbReference type="BRENDA" id="2.3.2.23">
    <property type="organism ID" value="2681"/>
  </dbReference>
  <dbReference type="BRENDA" id="6.2.1.45">
    <property type="organism ID" value="2681"/>
  </dbReference>
  <dbReference type="BRENDA" id="6.2.1.64">
    <property type="organism ID" value="2681"/>
  </dbReference>
  <dbReference type="PathwayCommons" id="P22314"/>
  <dbReference type="Reactome" id="R-HSA-8866652">
    <property type="pathway name" value="Synthesis of active ubiquitin: roles of E1 and E2 enzymes"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-983168">
    <property type="pathway name" value="Antigen processing: Ubiquitination &amp; Proteasome degradation"/>
  </dbReference>
  <dbReference type="SignaLink" id="P22314"/>
  <dbReference type="SIGNOR" id="P22314"/>
  <dbReference type="UniPathway" id="UPA00143"/>
  <dbReference type="BioGRID-ORCS" id="7317">
    <property type="hits" value="455 hits in 795 CRISPR screens"/>
  </dbReference>
  <dbReference type="ChiTaRS" id="UBA1">
    <property type="organism name" value="human"/>
  </dbReference>
  <dbReference type="EvolutionaryTrace" id="P22314"/>
  <dbReference type="GeneWiki" id="UBA1"/>
  <dbReference type="GenomeRNAi" id="7317"/>
  <dbReference type="Pharos" id="P22314">
    <property type="development level" value="Tbio"/>
  </dbReference>
  <dbReference type="PRO" id="PR:P22314"/>
  <dbReference type="Proteomes" id="UP000005640">
    <property type="component" value="Chromosome X"/>
  </dbReference>
  <dbReference type="RNAct" id="P22314">
    <property type="molecule type" value="protein"/>
  </dbReference>
  <dbReference type="Bgee" id="ENSG00000130985">
    <property type="expression patterns" value="Expressed in endometrium epithelium and 212 other cell types or tissues"/>
  </dbReference>
  <dbReference type="ExpressionAtlas" id="P22314">
    <property type="expression patterns" value="baseline and differential"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005737">
    <property type="term" value="C:cytoplasm"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005829">
    <property type="term" value="C:cytosol"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="HPA"/>
  </dbReference>
  <dbReference type="GO" id="GO:0070062">
    <property type="term" value="C:extracellular exosome"/>
    <property type="evidence" value="ECO:0007005"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005739">
    <property type="term" value="C:mitochondrion"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005654">
    <property type="term" value="C:nucleoplasm"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="HPA"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005634">
    <property type="term" value="C:nucleus"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005524">
    <property type="term" value="F:ATP binding"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="UniProtKB-KW"/>
  </dbReference>
  <dbReference type="GO" id="GO:0003723">
    <property type="term" value="F:RNA binding"/>
    <property type="evidence" value="ECO:0007005"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0004839">
    <property type="term" value="F:ubiquitin activating enzyme activity"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="MGI"/>
  </dbReference>
  <dbReference type="GO" id="GO:0006974">
    <property type="term" value="P:DNA damage response"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0016567">
    <property type="term" value="P:protein ubiquitination"/>
    <property type="evidence" value="ECO:0000318"/>
    <property type="project" value="GO_Central"/>
  </dbReference>
  <dbReference type="GO" id="GO:0006511">
    <property type="term" value="P:ubiquitin-dependent protein catabolic process"/>
    <property type="evidence" value="ECO:0000318"/>
    <property type="project" value="GO_Central"/>
  </dbReference>
  <dbReference type="CDD" id="cd01491">
    <property type="entry name" value="Ube1_repeat1"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="CDD" id="cd01490">
    <property type="entry name" value="Ube1_repeat2"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Gene3D" id="3.40.50.720">
    <property type="entry name" value="NAD(P)-binding Rossmann-like Domain"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Gene3D" id="2.40.30.180">
    <property type="entry name" value="Ubiquitin-activating enzyme E1, FCCH domain"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Gene3D" id="3.50.50.80">
    <property type="entry name" value="Ubiquitin-activating enzyme E1, inactive adenylation domain, subdomain 1"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Gene3D" id="3.40.50.12550">
    <property type="entry name" value="Ubiquitin-activating enzyme E1, inactive adenylation domain, subdomain 2"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Gene3D" id="1.10.10.2660">
    <property type="entry name" value="Ubiquitin-activating enzyme E1, SCCH domain"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Gene3D" id="3.10.290.60">
    <property type="entry name" value="Ubiquitin-activating enzyme E1, UFD domain"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR032420">
    <property type="entry name" value="E1_4HB"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR032418">
    <property type="entry name" value="E1_FCCH"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR042302">
    <property type="entry name" value="E1_FCCH_sf"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR045886">
    <property type="entry name" value="ThiF/MoeB/HesA"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR000594">
    <property type="entry name" value="ThiF_NAD_FAD-bd"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR018965">
    <property type="entry name" value="Ub-activating_enz_E1_C"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR042449">
    <property type="entry name" value="Ub-E1_IAD_1"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR038252">
    <property type="entry name" value="UBA_E1_C_sf"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR019572">
    <property type="entry name" value="UBA_E1_SCCH"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR042063">
    <property type="entry name" value="Ubi_acti_E1_SCCH"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR035985">
    <property type="entry name" value="Ubiquitin-activating_enz"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR018075">
    <property type="entry name" value="UBQ-activ_enz_E1"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR018074">
    <property type="entry name" value="UBQ-activ_enz_E1_CS"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR033127">
    <property type="entry name" value="UBQ-activ_enz_E1_Cys_AS"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR000011">
    <property type="entry name" value="UBQ/SUMO-activ_enz_E1-like"/>
  </dbReference>
  <dbReference type="NCBIfam" id="TIGR01408">
    <property type="entry name" value="Ube1"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="PANTHER" id="PTHR10953">
    <property type="entry name" value="UBIQUITIN-ACTIVATING ENZYME E1"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="PANTHER" id="PTHR10953:SF155">
    <property type="entry name" value="UBIQUITIN-LIKE MODIFIER-ACTIVATING ENZYME 1"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Pfam" id="PF16191">
    <property type="entry name" value="E1_4HB"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Pfam" id="PF16190">
    <property type="entry name" value="E1_FCCH"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Pfam" id="PF09358">
    <property type="entry name" value="E1_UFD"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Pfam" id="PF00899">
    <property type="entry name" value="ThiF"/>
    <property type="match status" value="2"/>
  </dbReference>
  <dbReference type="Pfam" id="PF10585">
    <property type="entry name" value="UBA_E1_SCCH"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="PRINTS" id="PR01849">
    <property type="entry name" value="UBIQUITINACT"/>
  </dbReference>
  <dbReference type="SMART" id="SM00985">
    <property type="entry name" value="UBA_e1_C"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="SUPFAM" id="SSF69572">
    <property type="entry name" value="Activating enzymes of the ubiquitin-like proteins"/>
    <property type="match status" value="2"/>
  </dbReference>
  <dbReference type="PROSITE" id="PS00536">
    <property type="entry name" value="UBIQUITIN_ACTIVAT_1"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="PROSITE" id="PS00865">
    <property type="entry name" value="UBIQUITIN_ACTIVAT_2"/>
    <property type="match status" value="1"/>
  </dbReference>
  <proteinExistence type="evidence at protein level"/>
  <keyword id="KW-0002">3D-structure</keyword>
  <keyword id="KW-0007">Acetylation</keyword>
  <keyword id="KW-0024">Alternative initiation</keyword>
  <keyword id="KW-0067">ATP-binding</keyword>
  <keyword id="KW-0963">Cytoplasm</keyword>
  <keyword id="KW-0903">Direct protein sequencing</keyword>
  <keyword id="KW-0225">Disease variant</keyword>
  <keyword id="KW-0436">Ligase</keyword>
  <keyword id="KW-0496">Mitochondrion</keyword>
  <keyword id="KW-0523">Neurodegeneration</keyword>
  <keyword id="KW-0547">Nucleotide-binding</keyword>
  <keyword id="KW-0539">Nucleus</keyword>
  <keyword id="KW-0597">Phosphoprotein</keyword>
  <keyword id="KW-1267">Proteomics identification</keyword>
  <keyword id="KW-1185">Reference proteome</keyword>
  <keyword id="KW-0677">Repeat</keyword>
  <keyword id="KW-0832">Ubl conjugation</keyword>
  <keyword id="KW-0833">Ubl conjugation pathway</keyword>
  <feature type="initiator methionine" description="Removed" evidence="26">
    <location>
      <position position="1"/>
    </location>
  </feature>
  <feature type="chain" id="PRO_0000194934" description="Ubiquitin-like modifier-activating enzyme 1">
    <location>
      <begin position="2"/>
      <end position="1058"/>
    </location>
  </feature>
  <feature type="repeat" description="1-1">
    <location>
      <begin position="63"/>
      <end position="199"/>
    </location>
  </feature>
  <feature type="repeat" description="1-2">
    <location>
      <begin position="459"/>
      <end position="611"/>
    </location>
  </feature>
  <feature type="region of interest" description="Disordered" evidence="5">
    <location>
      <begin position="1"/>
      <end position="47"/>
    </location>
  </feature>
  <feature type="region of interest" description="2 approximate repeats">
    <location>
      <begin position="63"/>
      <end position="611"/>
    </location>
  </feature>
  <feature type="short sequence motif" description="Nuclear localization signal">
    <location>
      <begin position="5"/>
      <end position="11"/>
    </location>
  </feature>
  <feature type="compositionally biased region" description="Polar residues" evidence="5">
    <location>
      <begin position="20"/>
      <end position="42"/>
    </location>
  </feature>
  <feature type="active site" description="Glycyl thioester intermediate" evidence="4">
    <location>
      <position position="632"/>
    </location>
  </feature>
  <feature type="binding site" evidence="2">
    <location>
      <position position="478"/>
    </location>
    <ligand>
      <name>ATP</name>
      <dbReference type="ChEBI" id="CHEBI:30616"/>
    </ligand>
  </feature>
  <feature type="binding site" evidence="2">
    <location>
      <position position="504"/>
    </location>
    <ligand>
      <name>ATP</name>
      <dbReference type="ChEBI" id="CHEBI:30616"/>
    </ligand>
  </feature>
  <feature type="binding site" evidence="2">
    <location>
      <position position="515"/>
    </location>
    <ligand>
      <name>ATP</name>
      <dbReference type="ChEBI" id="CHEBI:30616"/>
    </ligand>
  </feature>
  <feature type="binding site" evidence="2">
    <location>
      <position position="528"/>
    </location>
    <ligand>
      <name>ATP</name>
      <dbReference type="ChEBI" id="CHEBI:30616"/>
    </ligand>
  </feature>
  <feature type="binding site" evidence="2">
    <location>
      <begin position="576"/>
      <end position="577"/>
    </location>
    <ligand>
      <name>ATP</name>
      <dbReference type="ChEBI" id="CHEBI:30616"/>
    </ligand>
  </feature>
  <feature type="modified residue" description="N-acetylserine" evidence="26">
    <location>
      <position position="2"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="17">
    <location>
      <position position="4"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="21">
    <location>
      <position position="13"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="3">
    <location>
      <position position="21"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="3">
    <location>
      <position position="24"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="21 23 24 25 27">
    <location>
      <position position="46"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphotyrosine" evidence="3">
    <location>
      <position position="55"/>
    </location>
  </feature>
  <feature type="modified residue" description="N6-succinyllysine" evidence="3">
    <location>
      <position position="528"/>
    </location>
  </feature>
  <feature type="modified residue" description="N6-acetyllysine" evidence="22">
    <location>
      <position position="671"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphothreonine" evidence="21">
    <location>
      <position position="800"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="23 24">
    <location>
      <position position="810"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="3">
    <location>
      <position position="816"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="28">
    <location>
      <position position="820"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="21 27">
    <location>
      <position position="835"/>
    </location>
  </feature>
  <feature type="modified residue" description="N6-acetyllysine" evidence="22">
    <location>
      <position position="980"/>
    </location>
  </feature>
  <feature type="splice variant" id="VSP_055913" description="In isoform 2." evidence="18">
    <location>
      <begin position="1"/>
      <end position="40"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_085160" description="In VEXAS; somatic mutation; the underlying nucleotide substitution affects normal alternative translation initiation and leads to aberrant initiation from M-67 to produce a shorter protein with strongly reduced enzymatic activity." evidence="15">
    <original>M</original>
    <variation>L</variation>
    <location>
      <position position="41"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_085161" description="In VEXAS; somatic mutation; the underlying nucleotide substitution affects normal alternative translation initiation and leads to aberrant initiation from M-67 to produce a shorter protein with strongly reduced enzymatic activity." evidence="15">
    <original>M</original>
    <variation>T</variation>
    <location>
      <position position="41"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_085162" description="In VEXAS; somatic mutation; does not affect ubiquitin activating enzyme activity; does not affect subcellular localization; the underlying nucleotide substitution affects normal alternative translation initiation and leads to aberrant initiation from M-67 to produce a shorter protein with strongly reduced enzymatic activity." evidence="15">
    <original>M</original>
    <variation>V</variation>
    <location>
      <position position="41"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_043500" description="In dbSNP:rs2070169.">
    <original>R</original>
    <variation>H</variation>
    <location>
      <position position="447"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_043501" description="In SMAX2; dbSNP:rs80356545." evidence="11">
    <original>M</original>
    <variation>I</variation>
    <location>
      <position position="539"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_043502" description="In SMAX2; dbSNP:rs80356546." evidence="11">
    <original>S</original>
    <variation>G</variation>
    <location>
      <position position="547"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_071121" description="In SMAX2." evidence="14">
    <original>E</original>
    <variation>V</variation>
    <location>
      <position position="557"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Localizes to the cytoplasm." evidence="15">
    <location>
      <begin position="1"/>
      <end position="66"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Localizes to the cytoplasm; when associated with A-67." evidence="20">
    <location>
      <begin position="1"/>
      <end position="40"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Reduces phosphorylation." evidence="17">
    <original>S</original>
    <variation>A</variation>
    <location>
      <position position="4"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Loss of nuclear localization and a 90-95% decrease in the phosphorylation." evidence="17">
    <original>KKRR</original>
    <variation>AAAA</variation>
    <location>
      <begin position="8"/>
      <end position="11"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Localizes to the nucleus; when associated with A-67." evidence="15">
    <original>M</original>
    <variation>A</variation>
    <location>
      <position position="41"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Localizes to the nucleus; when associated with A-41. Localizes to the cytoplasm; when associated with 1-M--G-40 del." evidence="15">
    <original>M</original>
    <variation>A</variation>
    <location>
      <position position="67"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 1; CAA40296." evidence="18" ref="1">
    <original>D</original>
    <variation>G</variation>
    <location>
      <position position="190"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 1; CAA40296." evidence="18" ref="1">
    <original>E</original>
    <variation>Q</variation>
    <location>
      <position position="434"/>
    </location>
  </feature>
  <feature type="turn" evidence="30">
    <location>
      <begin position="52"/>
      <end position="54"/>
    </location>
  </feature>
  <feature type="helix" evidence="29">
    <location>
      <begin position="55"/>
      <end position="62"/>
    </location>
  </feature>
  <feature type="strand" evidence="29">
    <location>
      <begin position="74"/>
      <end position="78"/>
    </location>
  </feature>
  <feature type="helix" evidence="29">
    <location>
      <begin position="82"/>
      <end position="93"/>
    </location>
  </feature>
  <feature type="strand" evidence="29">
    <location>
      <begin position="97"/>
      <end position="102"/>
    </location>
  </feature>
  <feature type="helix" evidence="29">
    <location>
      <begin position="109"/>
      <end position="112"/>
    </location>
  </feature>
  <feature type="helix" evidence="29">
    <location>
      <begin position="120"/>
      <end position="122"/>
    </location>
  </feature>
  <feature type="helix" evidence="29">
    <location>
      <begin position="127"/>
      <end position="136"/>
    </location>
  </feature>
  <feature type="strand" evidence="29">
    <location>
      <begin position="140"/>
      <end position="142"/>
    </location>
  </feature>
  <feature type="strand" evidence="29">
    <location>
      <begin position="144"/>
      <end position="147"/>
    </location>
  </feature>
  <feature type="helix" evidence="29">
    <location>
      <begin position="153"/>
      <end position="156"/>
    </location>
  </feature>
  <feature type="strand" evidence="29">
    <location>
      <begin position="160"/>
      <end position="164"/>
    </location>
  </feature>
  <feature type="helix" evidence="29">
    <location>
      <begin position="169"/>
      <end position="181"/>
    </location>
  </feature>
  <feature type="strand" evidence="29">
    <location>
      <begin position="185"/>
      <end position="192"/>
    </location>
  </feature>
  <feature type="strand" evidence="29">
    <location>
      <begin position="195"/>
      <end position="201"/>
    </location>
  </feature>
  <feature type="strand" evidence="29">
    <location>
      <begin position="206"/>
      <end position="210"/>
    </location>
  </feature>
  <feature type="strand" evidence="29">
    <location>
      <begin position="219"/>
      <end position="224"/>
    </location>
  </feature>
  <feature type="strand" evidence="29">
    <location>
      <begin position="226"/>
      <end position="229"/>
    </location>
  </feature>
  <feature type="strand" evidence="29">
    <location>
      <begin position="231"/>
      <end position="234"/>
    </location>
  </feature>
  <feature type="strand" evidence="29">
    <location>
      <begin position="244"/>
      <end position="252"/>
    </location>
  </feature>
  <feature type="helix" evidence="29">
    <location>
      <begin position="257"/>
      <end position="259"/>
    </location>
  </feature>
  <feature type="strand" evidence="29">
    <location>
      <begin position="265"/>
      <end position="269"/>
    </location>
  </feature>
  <feature type="strand" evidence="29">
    <location>
      <begin position="271"/>
      <end position="273"/>
    </location>
  </feature>
  <feature type="strand" evidence="29">
    <location>
      <begin position="291"/>
      <end position="301"/>
    </location>
  </feature>
  <feature type="helix" evidence="29">
    <location>
      <begin position="306"/>
      <end position="311"/>
    </location>
  </feature>
  <feature type="helix" evidence="30">
    <location>
      <begin position="320"/>
      <end position="322"/>
    </location>
  </feature>
  <feature type="helix" evidence="29">
    <location>
      <begin position="326"/>
      <end position="343"/>
    </location>
  </feature>
  <feature type="helix" evidence="29">
    <location>
      <begin position="352"/>
      <end position="368"/>
    </location>
  </feature>
  <feature type="turn" evidence="29">
    <location>
      <begin position="371"/>
      <end position="373"/>
    </location>
  </feature>
  <feature type="helix" evidence="29">
    <location>
      <begin position="380"/>
      <end position="388"/>
    </location>
  </feature>
  <feature type="helix" evidence="29">
    <location>
      <begin position="395"/>
      <end position="413"/>
    </location>
  </feature>
  <feature type="strand" evidence="29">
    <location>
      <begin position="422"/>
      <end position="428"/>
    </location>
  </feature>
  <feature type="helix" evidence="30">
    <location>
      <begin position="429"/>
      <end position="431"/>
    </location>
  </feature>
  <feature type="turn" evidence="30">
    <location>
      <begin position="440"/>
      <end position="444"/>
    </location>
  </feature>
  <feature type="helix" evidence="30">
    <location>
      <begin position="452"/>
      <end position="455"/>
    </location>
  </feature>
  <feature type="helix" evidence="30">
    <location>
      <begin position="460"/>
      <end position="467"/>
    </location>
  </feature>
  <feature type="strand" evidence="30">
    <location>
      <begin position="470"/>
      <end position="474"/>
    </location>
  </feature>
  <feature type="helix" evidence="30">
    <location>
      <begin position="478"/>
      <end position="490"/>
    </location>
  </feature>
  <feature type="turn" evidence="30">
    <location>
      <begin position="491"/>
      <end position="493"/>
    </location>
  </feature>
  <feature type="strand" evidence="30">
    <location>
      <begin position="499"/>
      <end position="503"/>
    </location>
  </feature>
  <feature type="helix" evidence="30">
    <location>
      <begin position="510"/>
      <end position="514"/>
    </location>
  </feature>
  <feature type="helix" evidence="30">
    <location>
      <begin position="528"/>
      <end position="539"/>
    </location>
  </feature>
  <feature type="strand" evidence="30">
    <location>
      <begin position="545"/>
      <end position="548"/>
    </location>
  </feature>
  <feature type="helix" evidence="30">
    <location>
      <begin position="555"/>
      <end position="557"/>
    </location>
  </feature>
  <feature type="turn" evidence="30">
    <location>
      <begin position="558"/>
      <end position="560"/>
    </location>
  </feature>
  <feature type="helix" evidence="30">
    <location>
      <begin position="562"/>
      <end position="566"/>
    </location>
  </feature>
  <feature type="strand" evidence="30">
    <location>
      <begin position="570"/>
      <end position="573"/>
    </location>
  </feature>
  <feature type="helix" evidence="30">
    <location>
      <begin position="578"/>
      <end position="590"/>
    </location>
  </feature>
  <feature type="strand" evidence="30">
    <location>
      <begin position="595"/>
      <end position="601"/>
    </location>
  </feature>
  <feature type="strand" evidence="30">
    <location>
      <begin position="604"/>
      <end position="610"/>
    </location>
  </feature>
  <feature type="turn" evidence="30">
    <location>
      <begin position="612"/>
      <end position="614"/>
    </location>
  </feature>
  <feature type="helix" evidence="30">
    <location>
      <begin position="618"/>
      <end position="620"/>
    </location>
  </feature>
  <feature type="helix" evidence="30">
    <location>
      <begin position="632"/>
      <end position="635"/>
    </location>
  </feature>
  <feature type="helix" evidence="30">
    <location>
      <begin position="641"/>
      <end position="655"/>
    </location>
  </feature>
  <feature type="helix" evidence="30">
    <location>
      <begin position="657"/>
      <end position="668"/>
    </location>
  </feature>
  <feature type="helix" evidence="30">
    <location>
      <begin position="672"/>
      <end position="678"/>
    </location>
  </feature>
  <feature type="strand" evidence="30">
    <location>
      <begin position="681"/>
      <end position="683"/>
    </location>
  </feature>
  <feature type="helix" evidence="30">
    <location>
      <begin position="684"/>
      <end position="695"/>
    </location>
  </feature>
  <feature type="turn" evidence="31">
    <location>
      <begin position="696"/>
      <end position="698"/>
    </location>
  </feature>
  <feature type="helix" evidence="30">
    <location>
      <begin position="703"/>
      <end position="718"/>
    </location>
  </feature>
  <feature type="helix" evidence="30">
    <location>
      <begin position="720"/>
      <end position="728"/>
    </location>
  </feature>
  <feature type="turn" evidence="31">
    <location>
      <begin position="736"/>
      <end position="738"/>
    </location>
  </feature>
  <feature type="strand" evidence="30">
    <location>
      <begin position="740"/>
      <end position="745"/>
    </location>
  </feature>
  <feature type="strand" evidence="31">
    <location>
      <begin position="756"/>
      <end position="758"/>
    </location>
  </feature>
  <feature type="helix" evidence="30">
    <location>
      <begin position="759"/>
      <end position="776"/>
    </location>
  </feature>
  <feature type="helix" evidence="30">
    <location>
      <begin position="784"/>
      <end position="791"/>
    </location>
  </feature>
  <feature type="helix" evidence="30">
    <location>
      <begin position="817"/>
      <end position="820"/>
    </location>
  </feature>
  <feature type="helix" evidence="30">
    <location>
      <begin position="822"/>
      <end position="832"/>
    </location>
  </feature>
  <feature type="turn" evidence="30">
    <location>
      <begin position="836"/>
      <end position="838"/>
    </location>
  </feature>
  <feature type="helix" evidence="31">
    <location>
      <begin position="854"/>
      <end position="856"/>
    </location>
  </feature>
  <feature type="helix" evidence="30">
    <location>
      <begin position="858"/>
      <end position="872"/>
    </location>
  </feature>
  <feature type="helix" evidence="30">
    <location>
      <begin position="880"/>
      <end position="887"/>
    </location>
  </feature>
  <feature type="helix" evidence="30">
    <location>
      <begin position="895"/>
      <end position="912"/>
    </location>
  </feature>
  <feature type="turn" evidence="30">
    <location>
      <begin position="913"/>
      <end position="915"/>
    </location>
  </feature>
  <feature type="strand" evidence="30">
    <location>
      <begin position="924"/>
      <end position="928"/>
    </location>
  </feature>
  <feature type="turn" evidence="30">
    <location>
      <begin position="929"/>
      <end position="932"/>
    </location>
  </feature>
  <feature type="strand" evidence="30">
    <location>
      <begin position="933"/>
      <end position="937"/>
    </location>
  </feature>
  <feature type="strand" evidence="30">
    <location>
      <begin position="944"/>
      <end position="947"/>
    </location>
  </feature>
  <feature type="strand" evidence="30">
    <location>
      <begin position="950"/>
      <end position="953"/>
    </location>
  </feature>
  <feature type="strand" evidence="30">
    <location>
      <begin position="957"/>
      <end position="963"/>
    </location>
  </feature>
  <feature type="strand" evidence="30">
    <location>
      <begin position="965"/>
      <end position="969"/>
    </location>
  </feature>
  <feature type="helix" evidence="30">
    <location>
      <begin position="972"/>
      <end position="981"/>
    </location>
  </feature>
  <feature type="strand" evidence="30">
    <location>
      <begin position="986"/>
      <end position="992"/>
    </location>
  </feature>
  <feature type="strand" evidence="30">
    <location>
      <begin position="995"/>
      <end position="999"/>
    </location>
  </feature>
  <feature type="helix" evidence="30">
    <location>
      <begin position="1004"/>
      <end position="1011"/>
    </location>
  </feature>
  <feature type="strand" evidence="30">
    <location>
      <begin position="1012"/>
      <end position="1014"/>
    </location>
  </feature>
  <feature type="helix" evidence="30">
    <location>
      <begin position="1015"/>
      <end position="1022"/>
    </location>
  </feature>
  <feature type="strand" evidence="30">
    <location>
      <begin position="1023"/>
      <end position="1025"/>
    </location>
  </feature>
  <feature type="strand" evidence="30">
    <location>
      <begin position="1035"/>
      <end position="1041"/>
    </location>
  </feature>
  <feature type="strand" evidence="30">
    <location>
      <begin position="1045"/>
      <end position="1049"/>
    </location>
  </feature>
  <feature type="strand" evidence="30">
    <location>
      <begin position="1052"/>
      <end position="1056"/>
    </location>
  </feature>
  <feature type="initiator methionine" description="Removed" evidence="26">
    <location sequence="P22314-2">
      <position position="1"/>
    </location>
  </feature>
  <feature type="modified residue" description="N-acetylalanine" evidence="26">
    <location sequence="P22314-2">
      <position position="2"/>
    </location>
  </feature>
  <evidence type="ECO:0000250" key="1"/>
  <evidence type="ECO:0000250" key="2">
    <source>
      <dbReference type="UniProtKB" id="P22515"/>
    </source>
  </evidence>
  <evidence type="ECO:0000250" key="3">
    <source>
      <dbReference type="UniProtKB" id="Q02053"/>
    </source>
  </evidence>
  <evidence type="ECO:0000255" key="4">
    <source>
      <dbReference type="PROSITE-ProRule" id="PRU10132"/>
    </source>
  </evidence>
  <evidence type="ECO:0000256" key="5">
    <source>
      <dbReference type="SAM" id="MobiDB-lite"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="6">
    <source>
      <dbReference type="PubMed" id="1376922"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="7">
    <source>
      <dbReference type="PubMed" id="1447181"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="8">
    <source>
      <dbReference type="PubMed" id="1606621"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="9">
    <source>
      <dbReference type="PubMed" id="16139798"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="10">
    <source>
      <dbReference type="PubMed" id="16227972"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="11">
    <source>
      <dbReference type="PubMed" id="18179898"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="12">
    <source>
      <dbReference type="PubMed" id="1986373"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="13">
    <source>
      <dbReference type="PubMed" id="22456334"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="14">
    <source>
      <dbReference type="PubMed" id="23518311"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="15">
    <source>
      <dbReference type="PubMed" id="33108101"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="16">
    <source>
      <dbReference type="PubMed" id="7528747"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="17">
    <source>
      <dbReference type="PubMed" id="9099746"/>
    </source>
  </evidence>
  <evidence type="ECO:0000305" key="18"/>
  <evidence type="ECO:0000305" key="19">
    <source>
      <dbReference type="PubMed" id="1447181"/>
    </source>
  </evidence>
  <evidence type="ECO:0000305" key="20">
    <source>
      <dbReference type="PubMed" id="33108101"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="21">
    <source>
      <dbReference type="PubMed" id="18669648"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="22">
    <source>
      <dbReference type="PubMed" id="19608861"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="23">
    <source>
      <dbReference type="PubMed" id="19690332"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="24">
    <source>
      <dbReference type="PubMed" id="20068231"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="25">
    <source>
      <dbReference type="PubMed" id="21406692"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="26">
    <source>
      <dbReference type="PubMed" id="22814378"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="27">
    <source>
      <dbReference type="PubMed" id="23186163"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="28">
    <source>
      <dbReference type="PubMed" id="24275569"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="29">
    <source>
      <dbReference type="PDB" id="4P22"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="30">
    <source>
      <dbReference type="PDB" id="6DC6"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="31">
    <source>
      <dbReference type="PDB" id="7PYV"/>
    </source>
  </evidence>
  <sequence length="1058" mass="117849" checksum="4B413AAA75FAA562" modified="2002-10-25" version="3">MSSSPLSKKRRVSGPDPKPGSNCSPAQSVLSEVPSVPTNGMAKNGSEADIDEGLYSRQLYVLGHEAMKRLQTSSVLVSGLRGLGVEIAKNIILGGVKAVTLHDQGTAQWADLSSQFYLREEDIGKNRAEVSQPRLAELNSYVPVTAYTGPLVEDFLSGFQVVVLTNTPLEDQLRVGEFCHNRGIKLVVADTRGLFGQLFCDFGEEMILTDSNGEQPLSAMVSMVTKDNPGVVTCLDEARHGFESGDFVSFSEVQGMVELNGNQPMEIKVLGPYTFSICDTSNFSDYIRGGIVSQVKVPKKISFKSLVASLAEPDFVVTDFAKFSRPAQLHIGFQALHQFCAQHGRPPRPRNEEDAAELVALAQAVNARALPAVQQNNLDEDLIRKLAYVAAGDLAPINAFIGGLAAQEVMKACSGKFMPIMQWLYFDALECLPEDKEVLTEDKCLQRQNRYDGQVAVFGSDLQEKLGKQKYFLVGAGAIGCELLKNFAMIGLGCGEGGEIIVTDMDTIEKSNLNRQFLFRPWDVTKLKSDTAAAAVRQMNPHIRVTSHQNRVGPDTERIYDDDFFQNLDGVANALDNVDARMYMDRRCVYYRKPLLESGTLGTKGNVQVVIPFLTESYSSSQDPPEKSIPICTLKNFPNAIEHTLQWARDEFEGLFKQPAENVNQYLTDPKFVERTLRLAGTQPLEVLEAVQRSLVLQRPQTWADCVTWACHHWHTQYSNNIRQLLHNFPPDQLTSSGAPFWSGPKRCPHPLTFDVNNPLHLDYVMAAANLFAQTYGLTGSQDRAAVATFLQSVQVPEFTPKSGVKIHVSDQELQSANASVDDSRLEELKATLPSPDKLPGFKMYPIDFEKDDDSNFHMDFIVAASNLRAENYDIPSADRHKSKLIAGKIIPAIATTTAAVVGLVCLELYKVVQGHRQLDSYKNGFLNLALPFFGFSEPLAAPRHQYYNQEWTLWDRFEVQGLQPNGEEMTLKQFLDYFKTEHKLEITMLSQGVSMLYSFFMPAAKLKERLDQPMTEIVSRVSKRKLGRHVRALVLELCCNDESGEDVEVPYVRYTIR</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>